Clinical Trial Update: Sildenafil and Uteroplacental Perfusion [Phase 2, Phase 3]

View source ↗

Summary

This document reports an ongoing Phase 2/3 trial evaluating sildenafil to improve uteroplacental perfusion in fetal growth restriction, with the current status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fetal Growth Restriction

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Fetal Growth Retardation | Phase 2, Phase 3 | Status: UNKNOWN